论文部分内容阅读
两种治疗偏头痛的新药泽尼卡(Ｚｅｎｅｃａ)公司的佐米曲坦(ｚｏｌｍｉｔｒｉｐｔａｎ,商品名Ｚｏｍｉｇ)和葛兰素威康公司的那拉曲坦(ｎａｒａｔｒｉｐｔａｎ,商品名Ｎａｒａｍｉｇ)已首次分别获准进入英国和瑞典市场。不久将展开一场销售战,其他几种抗偏头痛药也准备进入市场
For the first time, two new migraine treatments, zolmitriptan (Zomig) and naratriptan (nalatriptan) of Zeneca, have been approved British and Swedish markets. There will soon be a sales war and several other anti-migraine drugs are also ready to enter the market